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Abstract
Background: Co-infection with malaria and HIV increases the severity and
mortality of both diseases, but the cytokine responses related to this co-infection
are only partially characterised. The aim of this study was to explore cytokine
responses in relation to severity and mortality in malaria patients with and without
HIV co-infection.
Methods: This was a prospective cross-sectional study. Clinical data and blood
samples were collected from adults in Mozambique. Plasma was analysed for 21
classical pro- and anti-inflammatory cytokines, including interleukins, interferons,
and chemokines.
Results: We included 212 in-patients with fever and/or suspected malaria and 56
healthy controls. Falciparum malaria was diagnosed in 131 patients, of whom 70
were co-infected with HIV-1. The malaria patients had marked increases in their
cytokine responses compared with the healthy controls. Some of these changes,
particularly interleukin 8 (IL-8) and interferon-c-inducing protein 10 (IP-10) were
strongly associated with falciparum malaria and disease severity. Both these
chemokines were markedly increased in patients with falciparum malaria as
compared with healthy controls, and raised levels of IL-8 and IP-10 were
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associated with increased disease severity, even after adjusting for relevant
confounders. For IL-8, particularly high levels were found in malaria patients that
were co-infected with HIV and in those who died during hospitalization.
Interpretations: Our findings underscore the complex role of inflammation during
infection with P. falciparum, and suggest a potential pathogenic role for IL-8 and IP-
10. However, the correlations do not necessarily mean any causal relationship, and
further both clinical and mechanistic research is necessary to elucidate the role of
cytokines in pathogenesis and protection during falciparum malaria.
Introduction
Human Immunodeficiency Virus (HIV) 1 and Plasmodium falciparum malaria are
two of the major lethal infectious diseases in sub-Saharan Africa, with 1.47 million
and 1.13 million deaths, respectively, in 2010 [1, 2]. Co-infection with malaria and
HIV presents challenges in both diagnosis and therapy and results in increased
severity and mortality of both infections [3–5].
Infection with P.falciparum is often associated with the activation of several
inflammatory pathways, resulting in systemic and local inflammatory responses
that involve the production of a wide range of cytokines,- from several cell types
including leukocyte subsets, endothelial cells and various tissues cells such as
macrophages. This inflammatory response during malaria infection could activate
anti-microbial responses in macrophages, T cells, granulocytes and endothelial
cells and thereby be beneficial for the host [6]. On the other hand, an
overwhelming inflammatory response could be detrimental for the host by
contributing to tissue destruction and excessive systemic inflammation that could
contribute to morbidity and mortality during falciparum malaria. Rodent studies
indicate that the malaria parasites themselves produce their own cytokines, which
interfere with the host’s immune response [7], but characterisation of the different
actors in the activated cytokine network during clinical falciparum malaria is not
fulfilled.
Although the immunological hallmark of HIV infection is a loss of CD4+ T cells
and the development of severe immunodeficiency, it is also characterised by a
state of chronic inflammation [8], and this non-resolving inflammation will
further contribute to immunodeficiency through mechanisms such as immune
exhaustion [9, 10]. This persistent low-grade immune activation will affect
immune responses to co-infection with other microbes, including P. falciparum.
However, in what way co-infection with HIV influences cytokine responses during
falciparum malaria is still only partly known. In addition, although there are
numerous studies on cytokine response during infection with P. falciparum, less is
known about the more detailed cytokine network and the relative importance of
different mediators with regard to disease severity and mortality in malaria
patients.
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Mozambique has one of the highest global incidences of co-infection with HIV-
1 and falciparum malaria, with a population HIV-1 prevalence of 11.5% that is
22.5% in Maputo (adults 15–49 years, 2009) and a malaria parasite prevalence of
27.7% in small children in Southern Mozambique (2007) [11, 12]. To characterise
inflammatory responses during infection with P. falciparum with and without co-
infection with HIV-1, we analysed a wide range of cytokines and related
inflammatory mediators in blood samples obtained at admission from adult
patients admitted to Central Hospital of Maputo in Mozambique with fever and/
or suspected malaria. The levels of the different mediators were related to disease
severity, mortality, and co-infection with HIV.
Methods
Study area and participants
The Central Hospital of Maputo is a public teaching hospital for Maputo’s 1.2
million citizens and a national referral hospital for Mozambique’s population of
22 million. From 8 January 2011 to 31 March 2011 and from 7 November 2011 to
14 March 2012, we conducted a prospective cohort study in all patients
consecutively admitted to the Medical Emergency Department in the Central
Hospital in Maputo every week from Sunday to Friday, as previously described
[13]. Most of the patients and most of the healthy controls came from the more
peripheral suburbs of Maputo city, including marshland. Malaria is meso-
endemic and most frequent from November to April, with P. falciparum
accounting for 95-100% of the malaria cases [12, 13]. The study was designed and
performed according to the Helsinki Declaration, as adopted by the 59th WMA
General Assembly, Seoul, Republic of Korea, October 2008, and was approved by
The National Ethical Committee at the Ministry of Health in Mozambique and
the Regional Ethical Committee in Eastern Norway. A signed consent or
fingerprint was obtained from each patient or next of kin and from the healthy
controls. Management of the patients was carried out according to the local
standard of care by the hospital’s doctors and staff.
Inclusion criteria
All non-pregnant adults $18 years with an axillary temperature $38.0 C̊ and/or
suspected malaria were included, provided written consent. As controls, we
included health care workers at the hospital, friends, and family members who
reported a subjective feeling of wellbeing and had a healthy appearance, as
evaluated by the researchers. Female healthy controls were not included if
suspected or confirmed pregnant. We defined ‘‘Suspected malaria’’ as a history of
fever, chills, headache, mental confusion, vomiting and/or diarrhoea, dyspnea,
myalgia, and/or general malaise, provided that there were no other symptoms,
findings on clinical examination, or additional diagnostic tests indicating other
infections. Additional diagnostic tests and exams were basic laboratory tests (e.g.,
IL-8 and IP-10 and Disease Severity in Falciparum Malaria and HIV-1
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Hemoglobin (Hb), WBC, differential count, ESR, AST, ALT, ALP, bilirubin, L
DH, creatinine); other blood tests (e.g., bacteriological and fungal culture and
antigen/antibodies for HIV-1, HIV-2, CMV, EBV, hepatitis B and C); urine
analysis (stix, micro, culture); Cerebrospinal fluid (CSF) analysis (erythrocytes,
WBC, differential count, protein, glucose, chloride, syphilis and cryptococcal tests,
bacteriological and fungal culture); sputum analysis for M. Tuberculosis with
microscopy (AAFB) and culture; stool analysis (e.g., microscopy for ova and cysts,
bacteriological culture); and cytological/histological and different radiological
exams, if indicated. ‘‘Malaria positive’’ (confirmed malaria) was defined as a
patient with a positive malaria PCR test. One patient who died with a positive
malaria PCR test was categorised as a non-malarial death, because he had a history
and clinical findings more compatible with tuberculous meningoencephalitis as
the cause of death. No malaria PCR was performed for two patients: they had a
positive HRP2-antigen test and were slide-positive with parasitemia 3+ and 5+,
respectively, and were defined as malaria positive. HIV-infected patients were
defined by a positive HIV serological test and/or a positive HIV PCR test. Malaria
severity was categorised according to the number of criteria fulfilled for severe
malaria, as defined by the WHO and adjusted to what could be measured locally,
as previously reported [13, 14]. The HIV disease severity was categorised
according to the WHO HIV clinical staging, I–IV [15].
Clinical data and blood sampling
We recorded a predefined set of clinical data from the patients’ files, which was
performed as part of the routine clinical examination on admission and on
follow-up during the hospital stay. The details are published elsewhere [13]. Blood
samples from the patients and controls were collected from a pre-alcohol-cleaned
peripheral vein and drawn into pyrogenic-free tubes with EDTA as a antic-
oagulant (plasma) or with no additive (serum).
The EDTA tubes were immediately put on melting ice and centrifuged within
30 minutes at 2000xg for 20 minutes to obtain platelet-poor plasma. The serum
tubes were allowed to clot at room temperature prior to being centrifuged at
1000xg for 10 minutes. The serum and plasma samples were stored in multiple
aliquots at 220 C̊ for 24 hours before being placed at 280 C̊. The samples were
thawed only once.
Laboratory analyses
According to the hospital routine and in line with standard procedures in the
laboratory of the Central Hospital of Maputo HIV-test (Determine, Abbot Japan
Co., Ltd. and Unigold, Trinity Biotech plc, Bray, Ireland), HRP-2 Rapid
Diagnostic Test for malaria (RDT) (2010–2011 First Response Malaria antigen P.
falciparum, Premium Medical Corporation Ltd., Daman, India; 2011–2012 ICT
Malaria P.f., ICT Diagnostics Cape Town, South Africa), malaria thick blood
slides (Giemsa 20% for 5 minutes), and other routine laboratory tests were
IL-8 and IP-10 and Disease Severity in Falciparum Malaria and HIV-1
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performed. Parasitemia was categorised in a thick smear as 1+ when 1–10
parasites/100 fields, 2+ when 11–100 parasites/100 fields, 3+ when 1–10 parasites/
field, 4+ when 11–100/field, and 5+ when .100 parasites/field [16]. In addition,
blood samples were taken separately for malaria and HIV PCR analyses, as
previously described [13]. An HCG-urine pregnancy test was performed for the
female patients of fertile age (Quick Vue, Quidel Corp., San Diego, CA, USA).
Cytokine assays
We analysed the plasma levels of interleukins (IL)-1b, IL-1 receptor antagonist
(IL1-ra), IL-2, IL-4, IL-5, IL-6, IL-7, IL-9, IL-10, IL-12 (p70), IL-13, IL-15, IL-17,
interferon (IFN)-c and tumour necrosis factor (TNF) as well as chemokines IL-8/
CXCL 8, eotaxin 1/CCL11, IFN-c-inducing protein 10 (IP-10/CXCL10),
monocyte chemotactic protein-1 (MCP-1/CCL2), and macrophage inflammatory
proteins 1a (MIP-1a/CCL3) and MIP-1b/CCL4 by a multiplex cytokine assay
(Bio-Plex Human Cytokine 27-Plex Panel; Bio-Rad Laboratories Inc., Hercules,
CA, USA) according to the instructions from the manufacturer. Cytokines that
were not detectable (all or most values below the lower detection limit) were
excluded from further analysis (i.e., IL-1b, IL-2, IL-4, IL-5, IL-12, IL-13, and IL-
15). There were no cytokine measurements above the upper detection limit.
Statistical analysis
For the cytokine data, we report the means, medians, and 25th and 75th
percentiles. Differences in categorical variables such as sex and HIV-status were
tested by chi-square tests. Differences in cytokine distributions between the
groups of study participants were tested by Mann-Whitney tests. Spearman rank
correlation was used for calculating correlations between cytokines in all malaria
patients (S1 Figure). Because this was an exploratory study with many inter-
dependent markers, we used no statistical corrections for multiple comparisons.
For multivariate analyses, due to high correlations among many of the cytokines,
ordinary multivariable logistic regression was not suitable. Instead we used Pelora,
a method constructed for supervised clustering in situations with strong
correlations among predictors (here i.e. cytokines), and many predictors
compared to the number of individuals (Pelora), which is recommended for such
cytokine analyses [17, 18], i.e. exactly the challenges we have in cytokine data [17].
Pelora finds groups of cytokines characterizing the property we are searching for,
as which group of cytokines are characteristic for the difference between all
malaria patients compared to healthy controls, for HIV positive malaria patients
compared to the HIV negative malaria patients and for those with severe malaria
compared to the patients with uncomplicated malaria. The ability of a cytokine
group to distinguish between patient groups, or patients versus controls, is given
as the ‘‘predictive ability’’, measured by the area under the operator characteristic
(ROC) curve [19], and where the closer to 1,- the better. Each cytokine in a group
may have a positive or a negative effect on the patient group membership
IL-8 and IP-10 and Disease Severity in Falciparum Malaria and HIV-1
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probability [17, 18]. According to the recommendations for this method, we
included clusters into the models until there was a levelling off in the increase in
predictive ability, and we adjusted for the effect of age, sex and where relevant
HIV status. Prior to Pelora, the cytokine values were log transformed to normalize
their skewed distribution, and the 1–2 most extreme values of the most skewed
cytokines were adjusted down to 3SD from the mean.
For analyses involving variables for which there were missing observations for
certain patients, these subjects were excluded; the number of included patients is
indicated in the tables. In the calculation of malaria severity, missing observations
were reckoned as ‘‘normal’’ in cases in which the investigation in question, e.g.,
bilirubin, was performed only on the clinical suspicion of specific organ
involvement. Most of the statistical analyses were performed with SPSS-21 (IBM
Corporation 1, New Orchard Road, Armonk, New York 10504–1722, USA, 914–
499–1900), but the Pelora analysis and the correlations plots were performed in R
version 3.0. (http://www.r-project.org) using the R-packages ‘‘supclust‘‘and
‘‘corrplot’’, respectively. There is a validation of all statistical methods used in S1
File.
Results
Characteristics of study participants
A total of 212 non-pregnant adults with fever and/or suspected malaria and 56
healthy controls were included. Of the 212 patients, 131 (62%) had malaria, and
70 of these (53%) were co-infected with HIV-1 (Fig. 1). All malaria patients had
P. falciparum; two also had double infection, one with P. vivax and the other with
P. malariae. Four of the healthy controls had HIV infection, including one with
P.ovale in addition. Those were excluded from further analysis rendering 52
healthy controls.
Among the malaria patients and healthy controls, the median ages were 38 years
(range 18–79 years) and 26 years (range 18–56 years), respectively: 45% and 41%
were women, and 98.5% and 96% were ethnic Mozambicans. There was a
significant difference between the malaria patients and healthy controls in relation
to age (p50.003), but not in relation to sex (p50.567). The malaria patients with
and without HIV co-infection showed no significant differences in age, sex, and
duration of symptoms; 66% of the patients (85/129) had severe malaria defined as
one or more severity criteria (missing observations for two patients). The malaria
patients with HIV co-infection in general had more severe disease, including in-
hospital mortality, as recently reported [13]. Of the malaria patients with HIV co-
infection, 59% (41/70) had severe HIV infection, with HIV WHO stage 3 or 4.
The HIV-infected patients had a median HIV viral load at 1.8 x 104 (range 0–8.3 x
106) HIV RNA copies/mL plasma (n562, missing blood sample analysis for eight
patients). Unfortunately, data on the CD4 T-cell counts were lacking in all except
11 patients who had a median of 206 CD4+ T cells/mL (range 14–632).
IL-8 and IP-10 and Disease Severity in Falciparum Malaria and HIV-1
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Overall cytokine response
The cytokine responses were extremely variable both inter- and intra-individually,
with levels ranging from below the lower detection limit to a 1000-fold increase
above this limit. Within the malaria patient group, several of the cytokines were
strongly inter-correlated, irrespective of co-infection with HIV, illustrating the
marked changes in and close connections between cytokines during malaria
infection (S1 Figure).
Cytokine levels in malaria patients compared with healthy
controls
In general, the malaria patients had a pronounced and broad cytokine response
compared with the healthy controls (Table 1). We observed significantly higher
levels of IL-1ra, IL-6, IL-8, IL-9, IL-10, eotaxin, IP-10, MCP-1, and MIP-1b.
Pelora first indicated an increased IP-10 response as the most important cytokine
for differentiating between malaria patients and healthy controls, with a predictive
ability of 0.973. The second most important group of cytokines were increased
Fig. 1. Study population, flow diagram. The focused sub-populations are encircled. Description of study population [13].
doi:10.1371/journal.pone.0114480.g001
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IL-8, IL-10, MIP-1b, and eotaxin and reduced IL-17 and MIP-1a with a high
combined estimated predictive ability of 0.969.
Cytokine levels in malaria patients with or without HIV co-
infection.
In the malaria patients with HIV co-infection compared with those without, there
was a significant increase in the levels of IL-8, eotaxin, and MIP-1a. (Table 2).
Pelora extracted high IL-8 and eotaxin and low TNF, with a predictive ability of
0.697. When analysing HIV-infected malaria patients with (n513) and without
(n533) antiretroviral therapy (ART) we saw no significant effects on cytokine
levels (data not shown). However, most of the patients on ART had less than three
months treatment and the data must therefore be interpreted with caution.
Cytokine levels related to disease severity
For patients with severe malaria (n584), as defined according to the adjusted
WHO criteria [13, 14], there were significantly increased levels of IL-8, IP-10 and
MIP-1b compared with the patients with uncomplicated malaria (n545)
(Table 3). Severe compared to uncomplicated malaria was associated with
significantly increased mortality rate with p50.017, with missing data for three
Table 1. Circulating levels of inflammatory mediators in adult falciparum malaria patients compared with healthy controls.
Healthy controls (n552) Malaria patients (n5129)1)
Mediator Median Mean Q1, Q3 Median Mean Q1, Q3 p2) Pelora3)
IL-1ra 118 171 61, 217 282 1089 145, 676 ,0.001
IL-6 8 13 5, 17 33 349 16, 85 ,0.001
IL-7 9 14 5, 20 12 18 5, 24 0.476
IL-8 12 20 6, 26 28 83 15, 54 ,0.001 X
IL-9 8 11 3, 17 18 24 10, 30 ,0.001
IL-10 4 10 2, 13 46 261 16, 135 ,0.001 X
IL-17 9 31 2, 51 1,68 23 2, 21 0.187 XQ
Eotaxin 6 15 2, 21 28 78 6, 75 ,0.001 X
INF-c 80 117 49, 138 92 177 57, 174 0.308
IP-10 258 428 212, 334 5877 12007 3062, 15230 ,0.001 X
MCP-1 9 12 6, 16 41 168 18, 152 ,0.001
MIP-1a 5 10 3, 13 7 10 4, 11 0.347 XQ
MIP-1b 29 35 21, 44 125 290 69, 276 ,0.001 X
TNF 42 60 22, 79 43 100 24, 78 0.951
Boldface type indicates statistical significance. The concentration of the various cytokines is given in pg/mL.
1) Data for two patients were missing.
2) Univariable analysis with the Mann-Whitney test.
3) Calculated by penalised logistic regression, where IP-10 appear as a much stronger indicator of malaria infection compared to the healthy controls, than
the other mentioned cytokines. The arrow indicates reduced cytokine levels in malaria patients compared with healthy controls.
doi:10.1371/journal.pone.0114480.t001
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patients. The Pelora analysis extracted increased IL-8 and IP-10 and reduced
MCP-1 levels, with a predictive ability of 0.756 (Table 3).
Categorising the study population into healthy controls and patients with
uncomplicated and severe malaria, there was a steady increase with increasing
severity in those cytokines that were associated with severity, i.e., IL-8 and IP-10
(Fig. 2).
Cytokine levels related to in-hospital mortality
During hospitalisation, ten of the malaria patients died, of which nine had a HIV
co-infection. The malaria patients who died had significantly raised levels of IL-6
(p50.006), IL-8 (p50.001), MCP-1 (p50.012), and MIP-1b (p50.010)
compared with the survivors.
Discussion
In the present study, marked changes in the cytokine response during infection
with P. falciparum were observed in malaria patients compared with healthy
controls. Some of these changes, particularly the IL-8 and IP-10 levels, were
strongly associated with falciparum malaria and disease severity. Both chemokines
were markedly increased in patients with falciparum malaria as compared with
Table 2. Circulating levels of inflammatory mediators in adult falciparum malaria patients with and without HIV-1 co-infection.
Falciparum malaria
HIV- (n561) HIV+ (n568)3) p1) Pelora2)
Mediator Median Mean Q1, Q3 Median Mean Q1, Q3
IL-1ra 273 1354 144, 459 380 861 143, 895 0.243
IL-6 28 512 15, 81 42 204 19, 103 0.166
IL-7 12 17 6, 22 13 19 4, 26 0.932
IL-8 21 77 13, 37 35 89 19, 76 0.002 X
IL-9 15 24 9, 29 19 25 10, 33 0.371
IL-10 40 322 14, 104 63 209 19, 266 0.281
IL-17 2 17 2, 16 5 28 2, 34 0.100
Eotaxin 19 95 6, 55 37 62 14, 89 0.012 X
INF-c 92 217 60, 170 90 141 49, 175 0.991
IP-10 5174 9307 2345, 12371 6637 14573 3603, 19947 0.050
MCP-1 35 186 16, 122 55 153 21, 177 0.151
MIP-1a 6 10 4, 8 8 9 5, 14 0.033
MIP-1b 119 322 60, 194 131 264 79, 369 0.183
TNF 45 141 25, 84 38 63 22, 74 0.666 XQ
Boldface type indicates statistical significance. The concentration of the various cytokines is given in pg/mL.
1) Univariable analysis with the Mann-Whitney test.
2) Calculated by penalised logistic regression. The arrow indicates reduced cytokine levels in HIV co-infected malaria patients compared with patients
without HIV.
3) Missing data for two patients.
doi:10.1371/journal.pone.0114480.t002
IL-8 and IP-10 and Disease Severity in Falciparum Malaria and HIV-1
PLOS ONE | DOI:10.1371/journal.pone.0114480 December 11, 2014 9 / 16
healthy controls, and raised levels of IL-8 and IP-10 were together with low MCP-
1 levels, associated with increased disease severity, even after adjusting for relevant
confounders. For IL-8, particularly high levels were also found in malaria patients
that were co-infected with HIV and in those who died during hospitalization.
Table 3. Circulating levels of inflammatory mediators in adult patients with uncomplicated and severe falciparum malaria.
Uncomplicated malaria (n545)1) Severe malaria2) (n584)1)
Mediator Median Mean Q1, Q3 Median Mean Q1, Q3 p3) Pelora4)
IL-1ra 276 1010 128, 485 287 1131 114, 774 0.327
IL-6 25.0 101 13, 60 40.0 481 18, 92 0.119
IL-7 12.0 15.7 6, 22 13.0 19.4 4, 26 0.937
IL-8 23.0 33.0 13, 22 34.0 110 19, 74 0.002 X
IL-9 14.0 17.0 7, 26 19.0 28.5 10, 33 0.079
IL-10 34.0 104 12, 118 53.0 344 20, 181 0.142
IL-17 1.68 18.02 2, 21 1.68 25.3 2, 23 0.457
Eotaxin 23.0 106 6, 51 37.0 63.3 7, 82 0.087
INF-c 87.0 236 60, 154 98.0 145 54, 178 0.786
IP-10 4343 6327 1926, 9007 8202 15050 4033, 18920 0.001 X
MCP-1 33.0 128 14, 100 53.0 189 21, 160 0.180 XQ
MIP-1a 6.00 7.17 3, 9 7.00 11.1 5, 14 0.096
MIP-1b 107 173 51, 207 130 352 86, 347 0.041
TNF 44.0 156 27, 72 42.0 70.4 23, 84 0.837
Boldface type indicates statistical significance. The concentration of the various cytokines is given in pg/mL.
1) Missing data for one patient.
2) Malaria severity criteria adjusted from WHO [15].
3) Univariable analysis with the Mann-Whitney test.
4) Calculated by penalised logistic regression. The arrow indicates reduced cytokine levels in the patients with severe malaria compared with those with
uncomplicated malaria.
doi:10.1371/journal.pone.0114480.t003
Fig. 2. Circulating levels of IL-8 and IP-10 in adult falciparum malaria patients according to malaria
severity. Circulating levels of IL-8 (A) and IP-10 (B) in adult malaria patients with increasing severity.
HC5Healthy controls; n552, UCM5 uncomplicated malaria n545, SM5 severe malaria n584. Missing data
one patient in each group of patients. Levels of mediators are presented as boxplots; the box shows the
interquartile range, the line through the box is the median, and the whiskers indicate the 10th and the 90th
percentiles. *p50.04, **p50.002, ***p,0.001, ****p50.001 (Mann-Whitney test).
doi:10.1371/journal.pone.0114480.g002
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Previous studies on the impact of cytokines on clinical outcome in malaria have
identified TNF, IFN-c, IL-1b, IL-6, IL-10, IL-12, transforming growth factor b
and IP-10 as important mediators, but data on IL-8in this setting are more limited
[20–24]. A Zambian study of falciparum malaria patients found no increased
levels of IL-8, but the sample size was small, and few patients had severe malaria
(8/30) [25]. In the present study, there was a strong and independent association
of IL-8 with disease severity in adult falciparum malaria,. In support of our
findings, in an older study from Thailand, IL-8 levels on admission were
correlated with malaria parasitemia and disease severity, but the highest IL-8 levels
were observed 14 days after admission, a time when viable parasites were no
longer found [26]. More recently, an increased frequency of the genotype IL-8-
251T/A, which leads to high IL-8 expression, has been associated with
susceptibility to severe falciparum malaria in a meso-endemic area in India [27].
In children with malaria, high plasma IL-8 and IP-10 has been associated with
increased severity and high cerebrospinal fluid IL-8 and IP-10 with mortality [28–
30]. Nonetheless, clinical presentation, immune response, and mortality are often
quite different in children compared with adults [31].
Several cells with relevance to severe falciparum malaria, including tissue
macrophages and endothelial cells, can release IL-8 when activated. It is tempting
to hypothesize that hemozoin and other parasite-related molecules can induce IL-
8 release in these cells. [32]. Moreover, P. falciparum secretes a functional
histamine-releasing factor homolog that induces IL-8 release from eosinophils
[33]. The role of IL-8 with relevance for falciparum malaria include its ability to
promote production of reactive oxygen species in monocytes and macrophages, to
induce endothelial cell activation and to promote T cell chemotaxis and CD8+ T
cell cytotoxicity [34]. IL-8 is a potent activator and chemo-attractant of
neutrophils, and based on studies in murine models, it has also been suggested
that neutrophils could be involved in sequestration and inflammation during
severe malaria [35]. Moreover, a study of Nigerian children found that neutrophil
extracellular traps (NETs) may induce pathology when they are infected with
falciparum-malaria, but the same mechanism could potentially also be beneficial
in adults by ‘‘trapping’’ the malaria parasites [36]. At the present, the role of
neutrophils in the pathogenesis of clinical malaria is unclear. [35]. The function of
the IL-8 receptor on erythrocytes has remained unclear to date, we can not
exclude a role for IL-8 in erythrocyte sequestering during falciparum malaria. [37–
39]. However, in spite of the hypothesis above, the role of IL-8 in malaria
pathogenesis and protection remains unclear.
Increased levels of IP-10 have been associated with increased severity and
mortality with cerebral malaria and with high viral load in HIV-infection [20, 40].
In the present study, we confirmed these findings by showing a strong and
independent association between plasma levels of IP-10 and disease severity in
patients with falciparum malaria. Also, in the Pelora analyses high IP-10 showed
the strongest association with falciparum malaria as compared with plasma levels
of healthy controls. In addition to high plasma levels of IL-8 and IP-10, low
plasma levels of MCP-1 were significant associated with disease severity during
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falciparum malaria. We have no explanation for this finding, but interestingly,
MCP-1 was suggested to be beneficial in relation to falciparum malaria in Fulani
children in Mali [29, 41], and the role of MCP-1 in malaria is still unclear.
Besides IL-8, MCP-1 and IP-10, several of the cytokines that were associated
with disease severity during falciparum infection belong to the CC or CXC
chemokine family, i.e., eotaxin, MIP-1a, and MIP-1b. All of these are chemo-
attractants for different types of leukocytes, including some with important roles
in malaria pathogenesis, as the eosinophil granulocytes. Thus, increased levels of
those chemokines have been associated with organ failure, such as in malaria-
associated acute respiratory distress syndrome (ARDS) and severe malaria, and
occasionally with mortality [20, 29, 32, 40, 42, 43].
We have previously shown that co-infection with HIV is significantly associated
with increased malaria severity and death [13]. Patients co-infected with
falciparum malaria and HIV had higher levels of IL-8, eotaxin and MIP-1a and
lower levels of TNF compared with the patients without HIV. Eotaxin has
previously been associated with anaemia in HIV-infected children with falciparum
malaria [43]. IL-8 has been implicated in inflammatory responses during HIV
infection as well as malaria [44]. Notably, although TNF has an established role in
the pathogenesis of HIV infection and malaria, we found low rather than high
levels of TNF, particularly in co-infected individuals. We have no clear
explanation for this finding but it could potentially reflect that other markers such
as soluble TNF receptors could be more reliable markers of TNF activity than TNF
itself. It could potentially also reflect that when measuring a wide range of
cytokines, trying to reflect the cytokine network, other conclusions may be
obtained than when analysing one or a few cytokines. Nonetheless, this finding
may underscore the complexity of the cytokine response during falciparum
malaria.
The present study has some limitations. First, although most patients were
severely ill, relatively few died, which limits conclusions concerning cytokine levels
and mortality. Second, even if the WHO HIV clinical staging is considered an
acceptable disease severity marker, the lack of information on CD4 and CD8 T cell
counts is still an important limitation, in relation to the influence of HIV co-
infection on the cytokine response during falciparum malaria. Third, since
malaria severity tends to increase in older age groups, at least in non-endemic
areas [45], the uneven age distribution may have ‘‘exaggerated’’ the differences in
cytokine response between the patients and the healthy controls. Ideally, we
should have had a selection process of the healthy controls achieving similar age
groups. Fourth, assuming that tests usually done only on clinical suspicion of
specific organ involvement were normal if not done, is not optimal, but still a
reality in a low resource setting. Fifth, a large number of statistical tests were
performed without adjusting for multiple comparisons. However, we consider it
less probable that the main findings could be due purely to statistical coincidences
because there was such a ‘‘systematic’’, significant trend in the IL-8 and IP-10
observations. In addition, the use of a statistical method (Pelora), which is
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particularly suited for the actual cytokine results, limits the influence of multiple
comparisons.
Conclusions
In the present prospectively designed study with consecutive inclusion of
falciparum malaria patients with and without HIV co-infection, we found marked
changes in the cytokine network during malaria infection. In particular, high
plasma levels of IP-10 and IL-8 were associated with falciparum malaria and
disease severity in infected individuals, and for IL-8, particularly high levels were
found in those that were co-infected with HIV. While several previous studies
have appointed IP-10, IL-8 has been less described in relation to severe malaria.
Our findings underscore the complex role of inflammation during infection
with P. falciparum. However, the correlations do not necessarily mean any causal
relationship, and further clinical and mechanistic research is necessary to elucidate
the role of cytokines in pathogenesis and protection during falciparum malaria.
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S1 Figure. The correlation between the different cytokines in all malaria
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